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Abstract Although mitochondrial dysfunction is implicated
in the pathogenesis of obesity, the molecular mechanisms
underlying obesity-related metabolic abnormalities are not
well established. We performed mitochondrial quantitative
proteomic and whole transcriptome analysis followed by
functional annotations within liver and skeletal muscles, using
fasted and non-fasted 16- and 48-week-old high-fat diet
(HFD)-fed and normal diet-fed (control group) wild-type
C56BL/6J mice, and hyperphagic ob/ob and db/db obese
mice. Our study identified 1,675 and 704 mitochondria-
associated proteins with at least two peptides in liver and
muscle, respectively. Of these, 221 liver and 44 muscle pro-
teins were differentially expressed (adjusted p values≤0.05)
between control and all obese mice, while overnight fasting
altered expression of 107 liver and 35 muscle proteins. In the
liver, we distinguished a network of 27 proteins exhibiting
opposite direction of expression changes in HFD-fed and
hyperphagic mice when compared to control. The network
centered on cytochromes P450 3a11 (Cyp3a11) and 4a14
(Cyp4a14), and fructose-bisphosphate aldolase B (Aldob)
proteins which bridged proteins cluster involved in Metabo-
lism of xenobiotics with proteins engaged in Fatty acid me-
tabolism and PPAR signaling pathways. Functional annota-
tions revealed that most of the hepatic molecular alterations,
which characterized both obesity and fasting, related to dif-
ferent aspects of energy metabolism (such as Fatty acid me-
tabolism , Peroxisome , and PPAR signaling ); however, only a
limited number of functional annotations could be selected
from skeletal muscle data sets. Thus, our comprehensive
molecular overview revealed that both obesity and fasting
states induce more pronounced mitochondrial proteome
changes in the liver than in the muscles.
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Introduction
Obesity is caused by an imbalance between energy intake and
energy utilization. The excess of energy is accumulated in
lipid droplets and prolonged caloric overconsumption results
in a positive energy balance and increasing body weight.
Several animal models were introduced to study behavioral
and metabolic consequences of overnutrition (Larter and Yeh
2008). Of them, both prolonged feeding with a high-fat diet
(HFD) and disruption of leptin signaling in leptin-deficient ob/
ob and leptin receptor-deficient db/db hyperphagic mice were
shown to result in obesity, insulin resistance, oxidative stress,
changes in lipid and glucose homeostasis, and hepatic
steatosis (Kennedy et al. 2010; Panchal and Brown 2011).
However, since dietary behaviors significantly differ between
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mice prolonged fed with HFD and hyperphagic mice fed with
normal diet (ND), they may exhibit differences also in molec-
ular response to the deposition of a body fat.
Several microarray-based studies of obese humans and
animal obesity models have been conducted during the past
decade. Most of these studies have focused on identifying the
transcriptional changes underlying the pathophysiology of
obesity, as well as the anti-obesity effects of dietary, pharma-
cological, and behavioral interventions (Sun 2007). In a con-
sequence, thousands of genes differentially expressed be-
tween lean and obese individuals have been identified, includ-
ing those related to the hepatic glucose and lipid metabolism,
insulin signaling, inflammation, coagulation, cell adhesion,
oxygen stress, and activity of chaperone (Sharma et al.
2006; Greco et al. 2008; Kim 2010; Naik et al. 2013). On
the contrary, a limited number of muscle transcriptomic stud-
ies have been reported so far. In one series of them, a short-
term feeding of mice with HFD changed the expression of
more than 1,000 genes in the skeletal muscle (de Wilde et al.
2008), but an 8-week HFD feeding induced rather small
alterations in the muscle transcriptome, with up-regulation of
only Fatty acid oxidation pathway (de Wilde et al. 2009).
Others studies revealed, however, that overall gene expression
in muscle, involved in fatty acid oxidation and biosynthesis,
was either decreased or obesity unresponsive (Kim 2010).
In contrast to microarray-based studies, only a few reports
on the proteomic profiling in obesity can be found in the
literature. In previous SDS–PAGE-based (Luo et al. 2012),
2D-based (Park et al. 2011; Eccleston et al. 2011), and 2D
differential in-gel electrophoresis-based (Douette et al. 2005;
Zhang et al. 2010; Kirpich et al. 2011; Thomas et al. 2012)
analyses of total liver proteins from rodents chronically exposed
to HFD, between 12 and 53 proteins reportedly
displayed significant obesity-related changes in expres-
sion. After short-term feeding with HFD, one hepatic
protein was significantly upregulated (Thomas et al.
2012). Recent quantitative proteomic analysis of total
liver proteome identified 1,131 proteins and expression
of 90 of them differed significantly between obese
HFD-fed rats and lean rats (Baiges et al. 2010).
Because the ability of mass spectrometry (MS)-based ap-
proaches to identify proteins expressed at low levels may be
enhanced when the analyzed peptides are restricted to selected
sub-proteomes (Adachi et al. 2007; Altelaar and Heck 2012),
we focused on mitochondrial (MT) proteome alterations. The
MT sub-proteome is suitable for the detection of molecular
alterations associated with obesity for several reasons: (1)
obesity is a consequence of energy imbalance; (2) cellular
energy is largely supplied by the MT oxidative phosphoryla-
tion system, which is regulated predominantly by insulin in
muscle, liver, and adipose cells; (3) transcription rates from
both MTand nuclear genomes are activated by insulin (Boirie
2003; Mikula et al. 2005), and genes that belong to MT
metabolic, catabolic, and biosynthetic pathways are highly
expressed in obese mice (Sharma et al. 2010); (4) MT dys-
functions have been implicated in the pathogenesis of obesity
and obesity-associated diseases, including metabolic syn-
drome, non-alcoholic fatty liver disease, type 2 diabetes, and
atherosclerotic heart disease (Samuel and Shulman 2012); and
finally, (5) the mammalian MT proteome consists of slightly
more than 1,000 proteins (Pagliarini et al. 2008).
Transcriptomic and proteomic results of the studies per-
formed in obesity models have not been integrated so far.
Furthermore, direct comparisons of liver and muscle MT
proteomes in obesity models have not been performed to date.
Here, MT proteomes were quantitatively evaluated using iso-
baric tags for relative and absolute quantitation (iTRAQ),
followed by liquid chromatography–tandem MS (LC–MS/
MS) analysis, and transcript measurements were generated
using microarray-based studies. Our studies reveal that com-
bining MT proteomic and transcriptomic surveys enriches the
functional analysis of obesity and fasting states in mice.
Combined data on differentially expressed genes and proteins
suggest that both obesity and fasting states result from highly
disordered metabolic processes which in prolonged obesity is
followed by deeper cellular and organismal systems deficien-
cies. In contrast, numbers of proteins and transcripts differen-
tially expressed in muscle samples were too low to be
assigned to any of functional pathways. Thus, altered expres-
sion of proteins and corresponding genes accompanied obesi-




Ninety-six 5-week-old male, certificated mice were purchased
from The Jackson Laboratory, USA. Of them, 48 mice were
wild-type (wt) C57BL/6J, 24 mice were homozygous
for the leptin gene mutation B6.V-Lepob/J (ob/ob), and
24 mice were homozygous for the leptin receptor gene
mutation B6.BKS(D)-Leprdb/J (db/db). Throughout the
study, mice were housed under temperature-controlled
(21±2 °C) and humidity-controlled (55±10 %) condi-
tions, with a 12-h light/dark cycle and ad libitum access
to food and water.
Ethics statement
Mice were housed in the Department of Genetics and Labo-
ratory Animals Breeding, at the Maria Sklodowska-Curie
Memorial Cancer Center and Institute of Oncology. Experi-
mental protocols were approved by The 2nd Local Ethical
Committee for Animal Research in Warsaw, Poland.
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Experimental design
Following purchase, mice were allowed 1-week adaptation,
during which all animals were fed ND (10 % of calories from
fat), containing 19.2 % protein, 67.3 % carbohydrate, and
4.3 % fat (D12450B; Research Diets, New Brunswick, NJ,
USA). At 6 weeks of age, 24 wt C57BL/6J mice were fed ND
(control group) and other 24wt C57BL/6Jmice were fed HFD
(HFD group) (60 % of calories from fat), containing 26.2 %
protein, 26.3 % carbohydrate, and 34.9 % fat (D12492; Re-
search Diets). The ob/ob and db/db mice were fed ND
throughout the entire experiment. To determine the effect of
fasting, half of the mice in each group were deprived of food
for a period of 18 h (between 3PM and 9AM next day) before
sacrifice. An overview of the experimental design is shown in
Fig. 1. At either 16 weeks or 48 weeks of age, mice were
weighed and sacrificed, followed by rapid collection of blood,
livers, and skeletal muscles. Fragments of fresh tissue samples
used for mitochondria isolation were placed into ice-cold
phosphate buffered saline (PBS). The remaining samples were
snap-frozen and stored at −72 °C until use.
mRNA extraction
Total RNAwas isolated from liver and muscle samples using
the RNeasy Plus Mini Kit (Qiagen, Germany) or TRIzol
(Invitrogen Co., CA, USA), respectively, followed by on-
column DNAse I digestion. The quality of RNA samples
was determined using an Agilent 2100 Bioanalyzer (Agilent
Technologies, CA, USA); samples used for microarray anal-
ysis displayed distinct peaks corresponding to intact 28S and
18S ribosomal RNA. Equal amounts of RNA (500 ng) were
combined from two randomly selected animals. This process
was performed for the six animals in each group, resulting in
three biological replicates of pooled RNA per trait (Table S1
depicts the sample pooling process).
Microarray analyses
The average signal from MouseRef-8 v2.0 Expression
BeadChips (AROS Applied Biotechnology, Aarhus, Den-
mark) was quantile normalized with no background correc-
tion. All computations were performed using R 2.15.0 soft-
ware (R Development Core Team 2011) with the
Bioconductor extension (Gentleman et al. 2004). Illumina
and Kyoto Encyclopedia of Genes and Genomes (KEGG)
(Kanehisa and Goto 2000) identifiers were mapped to genes
using lumiMouseAll.db (version 1.18.0), KEGG.db (version
2.8.0), and lumi (version 2.8.0) (Du et al. 2008) packages.
Measurements were filtered according to the ratio of the
interquartile range to the median. Only probes with a ratio
greater than 1:8 were selected for analysis.
In the further analysis, only the probe sets corresponding to
genes with detected proteins were considered in this study.
Differentially expressed genes were identified by a t test (Welch
variant) followed by the Benjamini–Hochberg p value correc-
tion for multiple hypotheses testing. Adjusted p values≤0.05
were considered significant. Microarray data was deposited in
Gene Expression Omnibus dataset GSE43691.
Functional analyses
The significance of mRNA and protein expression
changes related to each KEGG pathway was assessed
with the Kolmogorov–Smirnov (K-S) test. Resulting
p values were adjusted for multiple hypotheses testing
with the Benjamini–Hochberg algorithm and values
≤0.05 were considered significant.
Fig. 1 Overview of the
experimental design. At the
experiment endpoints, total RNA
and mitochondrial protein
extracts were combined from two
animals (depicted as differential
mice outlines) from each group of
six, generating three biological
replicate samples of pooled RNA
and mitochondrial proteins per
trait
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To explore the network of proteins and their contribution to
KEGG pathways, we used the STRING software (Szklarczyk
et al. 2011) that constructs functional protein-interaction net-
works and calculates its significance based on aggregated
experimental data.
Isolation of mitochondria
Mitochondria from 100 mg of mouse liver or hind limb
muscle tissues were isolated and purified using differential
centrifugation followed by ultracentrifugation in a discontin-
uous sucrose gradient (Ostrowski et al. 2004). The tissues
were minced into small pieces using scissors and washed with
ice-cold PBS. Minced muscles were incubated for 1 h in ice-
cold PBS supplemented with 10 mM EDTA and 0.05 %
trypsin to facilitate the homogenization process. Tissues
were homogenized using a Mitochondria/Cytosol Frac-
tionation Kit (BioVision, Milpitas, CA, USA). In brief,
samples were homogenized in Cytosol Extraction Buffer
supplemented with protease inhibitor cocktail, DTT, and
phosphatase inhibitor cocktail 1 and 2 (Sigma). The
homogenates were centrifuged (once for muscle, twice
for liver) for 10 min at 740×g and 4 °C, and then the
unbroken tissue, cells, and nuclei were discarded. The
supernatants were then centrifuged for 30 min at 10,
000×g and 4 °C to pellet the mitochondria. MT pellets
were suspended in ice-cold 0.25 M sucrose, layered on
1 M and 1.7 M discontinuous sucrose gradients spiked
with EDTA-free Complete Protease Inhibitor Cocktail
(Roche, Basel, Switzerland), and then centrifuged for
45 min at 70,000×g and 4 °C. Mitochondria recovered
from the gradient were diluted in ice-cold PBS and centri-
fuged for 20 min at 10,000×g and 4 °C. The purified mito-
chondria were stored at −80 °C.
Protein extraction
MT proteins were extracted with 8M urea in 2 % CHAPS and
concentrations were measured using a standard BCA assay.
Equal amounts of MT protein (100 μg) were combined from
two randomly selected animals; this process was per-
formed for the six animals in each group, resulting in
three biological replicates, similarly as for microarray
analyses (Table S1). Pooled samples were precipitated
using the ProteoExtract Protein Precipitation Kit
(Calbiochem, Germany), according to the manufacturer’s
protocol. Protein pellets were suspended in 40 μl disso-
lution buffer (0.5 M triethylammonium bicarbonate,
0.1 % SDS). To facilitate protein solubilization, samples
were disrupted using a Bioruptor ultrasonic homogenizer
(Diagenode, Belgium), using 10-s on–off cycles for
5 min at high intensity, and were then digested with
trypsin at 37 °C overnight.
iTRAQ labeling
The concentration of tryptic peptides was measured using a
modified BCA method (Kapoor et al. 2009). Equal amounts
of peptides (100 μg) were then reduced and cysteine-blocked
according to the iTRAQ protocol. Peptides derived from a
corresponding set of samples, comprising eight experimental
traits per age group, were labeled using the iTRAQ 8plex kit
(ABsciex, Framingham, MA, USA), as shown in Table S1.
Peptides were then mixed and fractionated simultaneously,
using isoelectric focusing (IEF) on 24 cm IPG strips (pH 3.5
to 4.5; GE Healthcare), as described previously (Mikula et al.
2011). Strips were cut into 14 sections and peptides were
extracted and stored at −72 °C. For each age group, three
strips were analyzed; each strip represented three biological
replicates (each replicate composed of MT proteomes derived
from two different, randomly selected animals).
LC–MS/MS
Analysis was performed using an Orbitrap MS (Thermo Sci-
entific, USA) coupled with a nanoAcquity LC system (Wa-
ters, USA). Spectrometer parameters were as follows: capil-
lary voltage, 2.5 kV; cone, 40 V; N2 gas flow, 0; and m /z
range, 300–2,000. Samples were loaded from the autosampler
tray (cooled to 10 °C) to the precolumn [Symmetry C18,
180 μm×20 mm, 5 μm (Waters)] using a mobile phase of
100 % MilliQ water acidified with 0.1 % formic acid.
Peptides were transferred to the nano-UPLC column
[BEH130 C18, 75 μm×250 mm, 1.7 mm (Waters)] by
a gradient of 5–30 % acetonitrile in 0.1 % formic acid
over 180 min at a flow rate of 250 nl/min and then directly
eluted to the ion source of MS. A blank run was performed
before each analysis to ensure the lack of cross-contamination
from previous samples.
LC–MS/MS data processing and analysis
All MS/MS data were analyzed using Mascot (version 2.3.02;
Matrix Science), which was configured to search the mouse
Swiss-Prot protein sequence database and reversed versions of
these sequences assuming semiTrypsin digestion. The data-
base search was performed with a fragment ion mass tolerance
of 0.8 Da and a peptide mass tolerance of 40 ppm.
ITRAQ8PLEX (N-TERM), ITRAQ8PLEX (K), and
METHYLTHIO (C) were specified in Mascot as fixed mod-
ifications; ITRAQ8PLEX (Y) and OXIDATION (M) were
specified as variable modifications. The statistical significance
of peptide identifications was assessed by a target/decoy da-
tabase search strategy, as described previously (Mikula et al.
2011). The quantitative iTRAQ analysis was performed using
a set of iTRAQ-labeled unique peptides, which were unam-
biguously assigned to a single protein, with an estimated false
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discovery ratio (FDR) of 0.01. The intensities of the iTRAQ
reporter ion peaks were corrected for isotope impurity and
then median-normalized to remove systematic bias. For the
statistical analysis of protein ratios, a permutation-based
test implemented in the Diffprot software was used
(Malinowska et al. 2012). Protein ratios with corrected
p values≤0.05 in pair-wise comparisons were consid-
ered significant. To assign proteins intracellular locali-
zation, both Swiss-Prot and Gene Ontology (GO)
(Ashburner et al. 2000) were used.
Results
In order to define molecular alteration associated with obesity
and fasting states in young and old obese mice, we used
hepatic and muscle samples from mice at 16 and 48 weeks
of age. Tenweeks of HFD feeding (16 weeks of mice age) was
chosen since at this time HFD-fed mice already show obesity
phenotypes, while some of 48-week-old obese mice started to
show enhanced symptoms of severe disease, including failure
to drink and eat, slower respiration, and impaired re-
sponsiveness to touch. A total of 12 mice per group
(given genotype, diet, and age) were analyzed. Six mice
in each group were deprived of food for a period of
18 h before sacrifice, according to typical mice meta-
bolic studies, when an overnight fasting (for 14–18 h)
has been usually employed (Ayala et al. 2010). Three
biological replicates per group were generated by com-
bining an equal amount of total RNA or MT protein
extracts from two randomly selected animals (Fig. 1).
As expected, the body weights of both 16-week-old and
48-week-old ob/ob, db/db, and HFD-fed wt mice (determined
immediately prior to sacrifice) were significantly higher than
the weights of age-matched ND-fed control mice (Fig. 2a).
Moreover, ob/ob and db/db mice at 16 weeks of age devel-
oped hyperinsulinemia, hyperglycemia, and moderate to se-
vere hepatic steatosis, and 48-week-old ob/ob, db/db as well
as wt C57BL/6J mice (in parallel with prolonged HFD feed-
ing) showed severe steatosis with moderate inflammation (our
yet unpublished observations). Compared with the non-
fasting condition, fasting for 18 h resulted in significantly
reduced liver weight in young ob/ob and HFD-fed mice, as
well as in both young and old control mice (Fig. 2b). Addi-
tionally, overnight fasting resulted in significantly re-
duced serum glucose concentration in young and old
control mice, as well as in young HFD-fed mice, and
reduced serum insulin concentration in all studied mice
(not shown). Although both the glucose and insulin
concentrations were significantly affected by the obese
state, we could not diagnose diabetes in any of the
obese groups (not shown) according to its accepted
diagnostic criteria for mice (Andrikopoulos et al. 2008).
Comparison of liver and muscle proteomes
Isolatedmitochondria were purified and the extracted peptides
were labeled with iTRAQ, fractionatedwith IEF, and analyzed
by LC–MS/MS. A total of 168 analytical LC–MS/MS runs
were performed, producing 2,566,757 MS/MS spectra. A
mouse Swiss-Prot protein sequence database search identified
17,606 and 10,967 peptides (estimated FDR≤0.01) that were
assigned to 2,746/1,675 and 1,484/704 proteins (identified by
at least one/two peptides) in liver and muscle samples, respec-
tively, which represented both MT and co-purified non-MT
proteomes (Table S2). Of these proteins, 904/490 were present
in data sets from both tissue types. MT proteins were then
selected using information deposited in the Swiss-Prot and
GO databases. According to the Swiss-Prot localization infor-
mation, 513/406 hepatic and 504/396 muscle MT proteins
a b
Fig. 2 Mouse total body weight (a) and liver weight (b) according to genotype and diet. HFD fed a high-fat diet, NF non-fasted, F fasted. *p <0.01,
**p <0.005, compared with the relevant control group; #p < 0.01 for liver weight comparison between non-fasted and fasted mice in a given group
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were identified by one/two peptides. According to the GO
term “mitochondria” (GO:0005739), 729/565 hepatic MT
proteins and 504/396 muscle MT proteins were identified by
one/two peptides. For clarity of further quantitative analyses,
we considered only proteins identified by at least two
peptides.
Proteins with an MT origin status in the Swiss-Prot data-
base represented 22 % and 53 % of all proteins isolated from
liver and muscle MT samples, respectively (Fig. 3). By com-
parison, MT proteins assigned by GO annotation represented
34 % of all hepatic proteins and 56 % of all muscle proteins
identified. Notably, the hnRNP K protein, which was
shown to be localized in mitochondria (Mikula et al.
2006), could not be attributed as a MT protein accord-
ing to either the Swiss-Prot or GO data sets. Addition-
ally, a recently published study on MT proteome map-
ping in living cells identified over 30 proteins within
the human MT matrix that were not previously linked to
mitochondria (Rhee et al. 2013). Since MT proteome is
still not well established, for further analyses we used
data for all proteins isolated with MT fractions.
To compare the protein abundances with the corre-
sponding mRNA transcript levels, we performed micro-
array measurements of pooled RNA samples combined
from same two animals as MT protein pools (Table S1).
In total, 48 microarrays were hybridized with liver sam-
ples and 48 additional microarrays were hybridized with
muscle samples.
Molecular alterations underlying obesity induced
by hyperphagia and HFD
Obesity-related differentially expressed proteins (bothMTand
co-purified non-MT) were analyzed in pair-wise comparisons
of non-fasted mice; the analysis was independent for each
group of obese mice. The analysis of liver samples identified
123, 115, and 67 proteins that distinguished (adjusted
p values≤0.05) young control mice from young ob/ob, db/
db, and HFD-fed mice, respectively, and also 74, 79, and 41
proteins that distinguished old control mice from old ob/ob,
db/db, and HFD-fed mice, respectively (Table 1). Analysis of
muscle samples revealed 19, 22, and 7 proteins that distin-
guished young control mice from young ob/ob, db/db, and
HFD-fed mice, respectively, and 5, 12, and 13 proteins that
distinguished old control mice from old ob/ob, db/db, and
HFD-fed mice, respectively (Table 1). The Venn diagrams
on Fig. 4 present the number of differentially expressed pro-
teins, common or unique between models of obesity. In sum,
221 proteins were significantly altered (adjusted p values≤
0.05) in liver (Table S3), and 44 proteins were altered in
muscle (Table S4).
Interestingly, a set of 27 hepatic proteins exhibited opposite
direction of expression changes in HFD-fed and hyperphagic
mice when compared to control (Table 2). Of them, 22 pro-
teins appeared as differential in 16-week-old animals. Molec-
ular context of these proteins interaction was next explored
with STRING database. Analysis revealed that these proteins
are highly interconnected (protein–protein interactions p val-
ue 5.66E−15) (Fig. 5) and significantly enriched for KEGG
fatty acids-related pathways (Peroxisome , PPAR signaling ,
Fatty acid metabolism ) and xenobiotics metabolism. The
central proteins of network are cytochrome P450 3a11
(Cyp3a11), fructose-bisphosphate aldolase B (Aldob), and
Cyp4a14 which bridged proteins cluster involved in Metabo-
lism of xenobiotics with components of Fatty acid metabo-
lism and PPAR signaling pathways. According to STRING,
the best documented associations in the network are between
Cyp3a11 and Cyp4a14 proteins. Eight of these 27 proteins
a b
Fig. 3 Subcellular identity of the 1,675 and 704 proteins identified by at least two peptides in mitochondrial fractions isolated from liver (a) and muscle
(b), respectively. Proteins were identified using the Swiss-Prot database
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showed over 3-fold difference in expression between hyper-
phagic and HFD-fed mice at any of age point; four proteins
were upregulated [glutathione S -transferase Mu 1 (Gstm1),
ATP-binding cassette sub-family D member 2 (Abcd2), acyl-
CoA desaturase 1 (Scd1), and fatty acid synthase (Fasn)] and
four proteins were downregulated [cytochrome P450 4V3
(Cyp4V3), liver carboxylesterase 31 (Es31), ornithine amino-
transferase (Oat), and serine-pyruvate aminotransferase
(Agxt)] in hyperphagic mice. There were no proteins detected
in the muscles that would have opposite expression in HFD-
fed and hyperphagic mice.
Next, all identified proteins and their corresponding
probe sets, from liver or muscle samples (Table S5 and
S6, respectively), were analyzed separately by annota-
tion to pre-defined KEGG pathways (Table S7). Liver
proteins could be assigned to 25 KEGG pathways in at
least one comparison, while their corresponding probe
sets were assigned to 18 pathways; of these, the Fatty
acid metabolism , Biosynthesis of unsaturated fatty
acids , Glycolysis /Gluconeogenesis , PPAR signaling ,
and Peroxisome pathways were common for the anno-
tations of both proteins and their corresponding probe
sets. Contrary to liver samples, no functional processes
were selected from either muscle RNA or muscle pro-
tein obesity data sets.
Molecular alterations underlying prolonged fasting
Overnight fasting-related differentially expressed proteins
were also independently identified in liver and muscle sam-
ples from each group of animals. In sum, fasting altered the
expression (adjusted p values≤0.05) of 107 proteins in liver
samples and 35 proteins in muscle samples (Tables S8 and
S9). The higher number of altered proteins was shown in both
young and old control mice, comparing with all obese mice
(Table 3). Noteworthy, a set of 45 hepatic proteins demon-
strated concordant abundance change in response to
fasting, in at least two groups of animals (Table S8);
38 of them were upregulated. When analyzed against
the STRING database, these 45 proteins constructed a
network significantly enriched in interactions that con-
tribute to KEGG pathways related to fatty acids (Per-
oxisome , PPAR signaling , Fatty acid metabolism ) and
amino acids metabolism (Fig. 6). Four and three of
differentially expressed proteins were common for all
groups of young or old mice, respectively (Fig. 7a, b),
while two of them, encoding components of cytochrome
P450 (Cyp4a14 and Cyp4a10), were changed concor-
dantly in both age groups (Table S8).
Table 1 Numbers of detected proteins and numbers of proteins that corresponded to measurable mRNA used for comparisons between obese mice and
appropriate control mice
16 weeks 48 weeks
ob/ob db/db HFD ob/ob db/db HFD
Hepatic proteins
Total analyzed proteins (proteins with corresponding
probe sets in filtered dataset)
1,242 (948) 1,250 (951) 1,260 (960) 1,077 (828) 1,080 (826) 1,067 (820)
Differentially expressed proteins 123 115 67 74 79 41
Skeletal muscle proteins
Total analyzed proteins (proteins with corresponding
probe sets in filtered dataset)
546 (419) 548 (421) 547 (420) 459 (353) 457 (351) 459 (353)
Differentially expressed proteins 19 22 7 5 12 13
a b
c d
Fig. 4 Venn diagrams presenting common and unique differentially
expressed proteins in different mice models of obesity
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In skeletal muscles, we found 10 consequently
changed proteins in at least two groups of animals
during fasting (Table S9). According to STRING, three
of them indicated interactions [myosin light chain 1/3
(Myl1), tropomyosin alpha-1 chain (Tpm1), and
calsequestrin-1 (Casq1)]; however, these 10 proteins
were not enriched in KEGG pathways. In muscle sam-
ples from 16-week-old animals, only wt mice (regard-
less of the diet) showed commonly changed proteins
(Fig. 7c).
Next, the functional analysis of transcriptomic and proteo-
mic data sets, differentiating non-fasting from fasting mice,
were performed (Table S10). Seventeen KEGG pathways
were attributed to changes in mRNA levels associated with
overnight fasting. One of these pathways (Peroxisome ) was
selected in all groups of animals, and three others (Fatty acid
metabolism ; PPAR signaling ; and Valine , leucine , and iso-
leucine degradation ) were selected in at least four out of eight
animal groups. Differentially expressed hepatic proteins could
be assigned to nine KEGG pathways, but only in three groups
of old obese mice. Of these nine pathways, five path-
ways (Peroxisome , Fatty acid metabolism , and three
neurodegenerative diseases) were also selected upon
corresponding probe sets data (Table S10). Functional
analysis of muscle samples revealed 21 KEGG path-
ways selected from proteomic data sets and seven se-
lected from transcriptomic data sets (Table S11). Com-
mon protein and RNA-related functional annotations
were limited to only two groups of mice: young HFD-
fed mice and old control mice.
Table 2 Differentially regulated proteins between hyperphagic and HFD-fed mice
Sp. acc. Name Gene 16 weeks 48 weeks
ob/ob db/db HFD ob/ob db/db HFD
Q61285 ATP-binding cassette sub-family D member 2 Abcd2 3.44 2.95 0.59 1.72 1.65
P10649 Glutathione S-transferase Mu 1 Gstm1 2.05 2.64 0.58 1.82 1.55
P13516 Acyl-CoA desaturase 1 Scd1 1.73 0.53
P19096 Fatty acid synthase Fasn 1.65 1.64 0.58 1.83 1.56 0.57
Q64459 Cytochrome P450 3A11 Cyp3a11 1.35 1.51 0.66 1.50 1.18
Q91Y97 Fructose-bisphosphate aldolase B Aldob 1.89 1.62 0.74 2.12 1.50
P17182 Alpha-enolase Eno1 1.69 1.40 0.80 1.74 1.54
Q64521 Glycerol-3-phosphate dehydrogenase, mitochondrial Gpd2 1.64 1.61 0.87 1.60 1.50 1.43
O35728 Cytochrome P450 4A14 Cyp4a14 2.12 2.04 0.76 0.47
Q9DBM2 Peroxisomal bifunctional enzyme Ehhadh 1.75 1.84 0.81 0.68
Q60597 2-Oxoglutarate dehydrogenase, mitochondrial Ogdh 1.41 0.78
P25688 Uricase Uox 1.26 0.79 0.88
P07724 Serum albumin Alb 1.36 0.83
Q8VDN2 Sodium/potassium-transporting ATPase subunit alpha-1 Atp1a1 0.84 1.50 1.27
O35423 Serine-pyruvate aminotransferase, mitochondrial Agxt 0.43 1.96 0.62 0.53
Q63880 Liver carboxylesterase 31 Es31 0.38 0.28 1.22 0.32 0.60
P29758 Ornithine aminotransferase, mitochondrial Oat 0.38 0.47 1.58 0.58 0.46 0.71
Q9DBW0 Cytochrome P450 4V3 Cyp4v3 0.43 0.42 1.38 0.56
P58710 L-Gulonolactone oxidase Gulo 0.54 0.62 1.32
Q91VS7 Microsomal glutathione S-transferase 1 Mgst1 0.81 0.81 1.24 0.81
P14211 Calreticulin Calr 0.75 0.80 1.09
P26150 3 Beta-hydroxysteroid dehydrogenase/Delta 5→4-isomerase type 3 Hsd3b3 0.62 1.44
Q91WN4 Kynurenine 3-monooxygenase Kmo 0.70 1.29 0.64 0.70
O35488 Very long-chain acyl-CoA synthase Slc27a2 1.15 0.80 0.83
Q9DCM2 Glutathione S-transferase kappa 1 Gstk1 1.62 0.78 0.72
P41216 Long-chain-fatty-acid–CoA ligase 1 Acsl1 1.72 0.79 0.70
Q9CW42 MOSC domain-containing protein 1, mitochondrial Mosc1 1.41 0.81
List of differentially expressed hepatic proteins with an opposite direction of changes in non-fasted HFD-fed mice and non-fasted hyperphagic mice as
compared with control. The presented fold change (FC) values are relative to non-fasted control animals with adjusted p value ≤0.05. Bolded are gene
names of eight proteins with expression level different with FC >3 between hyperphagic and HFD-fed mice
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Discussion
In this study, for the first time, we demonstrate that the extent
of MT proteome changes is greater in the liver than muscles in
states of well-established models of obesity. The difference
was captured in the number of identified proteins—1,675 and
704 proteins represented by at least two peptides, for liver and
muscles, respectively, as well as in the number of differentially
expressed proteins in these two tissues (Figs. 4 and 7). In the
liver, but not in skeletal muscles, we point functional changes,
depicted by KEGG pathways, distinctive to obesity (Table S7)
and fasting (Table S10) conditions by collating MT proteome
Fig. 5 A protein interaction
network constructed with
STRING (Szklarczyk et al. 2011)
for a set of 27 hepatic proteins
with an opposite direction of
expression in HFD-fed and
hyperphagic mice when
compared to control. Stronger
evidences of associations are
represented by thicker network
edges. Node color depicts
significantly enriched KEGG
category assigned to a protein by
STRING database in a set of 27
proteins while white nodes
indicate proteins without
functional annotation
Table 3 Numbers of detected proteins and numbers of proteins that corresponded to measurable mRNA used for comparisons between mice subjected
to prolonged fasting or non-fasting in each group
16 weeks 48 weeks
Control ob/ob db/db HFD Control ob/ob db/db HFD
Hepatic proteins
Total analyzed proteins (proteins with
corresponding probe sets in filtered dataset)
1,265 (961) 1,249 (953) 1,257 (957) 1,249 (949) 1,034 (794) 1,096 (843) 1,082 (829) 1,056 (813)
Differentially expressed proteins 51 31 23 22 28 21 16 21
Skeletal muscle proteins
Total analyzed proteins (proteins with
corresponding probe sets in filtered dataset)
554 (428) 552 (423) 549 (425) 550 (423) 461 (355) 461 (353) 457 (350) 454 (349)
Differentially expressed proteins 12 10 2 14 3 2 3 2
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dataset with corresponding transcripts. As expected, these
pathways are mostly related to fatty acids metabolism
pathways.
Difficulty defining the mitochondrial proteome
Depending on the method used to identify proteins, mitochon-
dria are thought to contain between 1,000 and 1,500 nuclear-
encoded proteins. However, no single method can identify all
MT proteins; some are expressed at levels too low to detect,
while others are expressed exclusively by specific cell types
(Calvo andMootha 2010). Furthermore, distinguishing genuine
MT proteins using an MS approach may be obscured by
the co-purification of protein contaminants from other
membranous and MT-associated organelles (Pagliarini
et al. 2008). MT proteins are directed toward the MT
outer membrane either during or after translation, as
their synthesis can be initiated and completed on cyto-
plasmic ribosomes or initiated in the cytoplasm and
completed within mitochondria. Synthesis of some MT
proteins takes place in the vicinity of the organelle
where their corresponding mRNAs are bound to mito-
chondria before the initiation of translation (Pagliarini
et al. 2008).
Skeletal muscle contains two types of mitochondria:
intermyofibrillar mitochondria, which provide most of the en-
ergy used for muscle contraction; and subsarcolemmal mito-
chondria, which generate ATP for membrane functions
(Ferreira et al. 2010). Most of the top ten skeletal muscle
proteins identified by the greatest number of peptides in this
study represented components associated with the assembly or
function of vertebrate skeletal muscles, including several iso-
forms of myosin (Table S2). Therefore, a substantial proportion
of proteins identified as non-MT might originate from organ-
elles that are essential for MT protein translation and that co-
localize topographically and/or functionally with mitochondria.
Finally, some of proteins with actual MT localization might not
be assigned to mitochondria in available databases (Rhee et al.
2013). With this in mind, the differentially expressed proteins
and their corresponding probe sets were quantitatively analyzed
and functionally annotated to pre-defined KEGG signaling
pathways regardless of the established potential subcellular
localization of the proteins isolated in MT fractions.
Obesity-related protein changes and functional annotations
We identified 221 hepatic and 44 muscle proteins that were
expressed differently in control mice than in any obese mice
Fig. 6 STRING interaction
network (Szklarczyk et al. 2011)
for a set of 45 hepatic proteins
with concordant expression
during fasting in at least two
groups of mice. Stronger
evidences of associations are
represented by thicker network
edges. Node color depicts
significantly enriched KEGG
category assigned to a protein by
STRING database in a set of 45
proteins while white nodes
indicate proteins without
functional annotation
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(Tables S3 and S4). Twenty-nine of the differentially
expressed hepatic proteins identified in this study were also
reported as obesity-related markers in at least one of five
previously published reports (Douette et al. 2005; Zhang
et al. 2010; Baiges et al. 2010; Kirpich et al. 2011; Thomas
et al. 2012) (Table S12). Twelve of these proteins exhibited the
same direction of change as in a proteomic study by Douette
et al. performed on hepatic MT fraction (Douette et al. 2005).
In the current study, proteins differentially expressed in
relation to obesity, assigned to Fatty acid metabolism
pathway, were upregulated in at least one obesity model
and time point, and included long-chain fatty acyl-CoA syn-
thetase (Acsm1), carnitine O -palmitoyltransferases (Cpt),
trifunctional mitochondrial enzyme subunits α and β
(Hadh), medium-chain specific acyl-CoA dehydrogenase
(Acadm), 3-hydroxyacyl-CoA dehydrogenase (Hsd17b10),
acyl-CoA oxidase (Acox1), 3-ketoacyl-CoA thiolases
(Acaa), and 3,2-trans-enoyl-CoA isomerases (Dci)
(Table S3). Also, among differentially expressed proteins
assigned to Glycolysis /Gluconeogenesis pathway, most were
upregulated, i.e., Aldob, α-enolase (Eno), aldehyde dehydro-
genase (Aldh), L -lactate dehydrogenase (Ldha), and
glyceraldehyde-3-phosphate dehydrogenase (Gapdh)
(Table S3). Although for skeletal muscles, non-functional
KEGG pathway was selected from either mRNA or protein
data sets, several proteins participating in fatty acid or glucose
metabolism processes were also upregulated (Table S4).
In ob/ob mice, the combination of glucose overproduction
and enhanced fatty acid synthesis was observed, leading to
further increase of insulin secretion and resistance (McGarry
1992). Consistently in our study, Fasn was also upregulated in
young and old hyperphagic mice (mean FC=1.67); however,
it was downregulated in HFD-fed mice (mean FC=0.58).
Also, acetyl-CoA carboxylase 1 (Acaca) was downregulated
in young mice fed with HFD, whereas different isoforms of
acyl-CoA thioesterase (Acot) and Scd1, assigned to Biosyn-
thesis of unsaturated fatty acids KEGG pathway, were upreg-
ulated in hyperphagic mice, in opposite to HFD-fed mice
(Table S3).
For 27 obesity-related differentially expressed proteins, the
direction of change in HFD-fed mice was opposite to that
observed in hyperphagic mice (Table 2 and Fig. 5). STRING
analysis reported these proteins as significantly networked
and 13 of them were annotated to various metabolic KEGG
pathways, with Peroxisome ,PPAR signaling , andMetabolism
of xenobiotics by cytochrome 450 as the most significantly
enriched. Interaction between two cytochrome P450 compo-
nents (Cyp3a11 and Cyp4a14) and Aldob are central elements
of cluster network. Expression levels of eight (Scd1, Gstm1,
Abcd2, Fasn, Cyp4V3, Es31, Oat, and Agxt) of these 27
proteins were changed by more than 3-fold when compared
hyperphagic and HFD-fed mice. These differences in the
direction of change could be due to specific diet composition,
the later onset of adverse hepatic biochemical changes in
HFD-induced obesity, or different regulation of some meta-
bolic processes in obesity induced by hyperphagia and by
HFD. Scd1 protein levels were 3.3-fold higher in hyperphagic
mice than in HFD-fed mice, which is consistent with the
Scd1-related model of obesity. A Scd1 knock-out mutation
in ob/ob mice disrupts the conversion of saturated long-chain
fatty acids to monounsaturated fatty acids and significantly
suppresses both obesity and hepatic steatosis (Cohen et al.
2002). The transient downregulation of Scd1 induces a similar
restoration of energy balance and metabolism in HFD-fed
mice (Jiang et al. 2005).
Together, these results suggest that fatty acid synthesis
processes might be differentially regulated in a course of
obesity induced by leptin deficiency and by HFD. In opposite
to HFD-fed mice, young hyperphagic mice show likely en-
hanced potency involved in the lipogenesis processes.
It was shown that HFD activates hepatic peroxisomal me-
tabolism of very long-chain and branched-chain fatty acid
(Kozawa et al. 2011). In Zucker rats model of obesity, perox-
isomal oxidation products were shown to enter mitochondria,
providing the possibility tomaintain lipid disposal, even under
insulin resistance condition (Noland et al. 2007). Proteomic
survey in the current study confirmed the enhanced hepatic
peroxisomal capacity in fatty acid oxidation. Among 221
differentially regulated proteins in liver, 24 were assigned to
Peroxisome pathway and most of them were upregulated in
a b
c d
Fig. 7 Venn diagrams presenting common and unique differentially
expressed proteins during overnight fasting in obese and control mice
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16-week-old mice; six of them only in hyperphagic mice
(Table S3). In old animals, differential expression of proteins
involved in peroxisomal oxidative activity was not indicated,
confirming that metabolic processes were altered predomi-
nantly in early phase of chronic obesity.
Combined hepatic proteomic- and transcriptomic-based
functional annotations indicated that in young obese mice,
alterations almost exclusively reference to metabolic process-
es (Table S7). Among them, mainly lipid metabolism (Fatty
acid metabolism , Biosynthesis of unsaturated fatty acids ,
PPAR signaling , and Peroxisome ) and carbohydrate metabo-
lism (Glycolysis /Gluconeogenesis ) were deregulated. Both
classes of processes are essentially involved in an energy
production and storage, although, comparing with other nu-
trient groups, fatty acids are the most efficient energy source.
Enhanced fatty acids metabolism and dysregulated gluco-
neogenesis were previously indicated in polygenic and diet-
induced obesity mouse models, both by total hepatic gene
expression analysis (Becker et al. 2004) and proteomic study
of adipocyte membranes (Ho et al. 2013). Similarly, a liver
MT proteins study shows coordinated upregulation of bioen-
ergetic processes during type 2 diabetes progression in rats as
potential compensation for the decreased glucose metabolism
by insulin resistance (Deng et al. 2010).
Defective MToxidation of fatty acid and the production of
reactive oxygen species (ROS) may lead to the hepatic but not
muscle lipid accumulation (Civitarese et al. 2007; Machado
et al. 2012). Feeding with HFD for 3 days in men and for
3 weeks in mice downregulates genes necessary for muscle
OXPHOS and mitochondria biogenesis (Sparks et al. 2005),
and prolonged consumption of a high-caloric diet has been
reported as associated with a reduction of MT capacity and
respiration in mouse skeletal muscle (Bonnard et al. 2008) and
rat liver (Vial et al. 2011). However, other studies on obese
mice showed increased rather than decreased mitochondria
density, respiration, enzyme, activity and fatty acid oxidation
(Hoeks et al. 2011); expansion of muscle adipose depots in
obese humans did not associate with MT dysfunction
(Machado et al. 2012); and in obese rats, MT dysfunction
was found to be a late event (Chanséaume et al. 2007). In
accordance with these results, our study revealed that in the
liver, but not in skeletal muscles, changes in MT proteins and
their corresponding transcripts mostly related to fatty acids
metabolism pathways.
Fasting-related protein and functional changes
An overnight fast causes enhanced metabolic stress in mice
associated with a significant reduction of liver weight. This
effect was particularly pronounced in lean mice in which liver
mass was decreased by approximately 30 % (Fig. 2b). Al-
though not significant, a bodyweight reduction of approximate-
ly 15%was also noted in both lean and obesemice, similarly as
reported previously (Heijboer et al. 2005). A suppressive effect
of overnight fasting on serum insulin levels was also confirmed
in all animals studied (not shown). However, although insulin is
responsible for restraining hepatic glucose production in the
fasted state and maintaining normal blood glucose concentra-
tions (Heijboer et al. 2005), only lean (control and young HFD-
fed) mice exhibited decreased glucose levels (not shown).
Proteomic analysis revealed 107 proteins in liver samples
and 35 proteins in muscle samples that distinguished all fasted
from all non-fasted mice (Tables S8 and S9). The greatest
number of overnight fasting-altered hepatic proteins was indi-
cated in lean control mice comparing with any of obese ones
(Table 3). Moreover, only few differentially expressed proteins
were common between mice with obesity induced by HFD
feeding and genetically, presumably indicating differences in
molecular mechanisms underlining the acute fasting in both
obesity models. Our study indicated 45 hepatic proteins with
concordant expression change in at least two groups of animals
(Fig. 6). Of these, Cyp4a14 and Cyp4a10 proteins, belonging to
cytochrome P450 system, were consequently upregulated in all
groups of animals. These proteins are encoded by well-
established peroxisome proliferator-activated receptor
(PPAR)α-responsive genes (Patsouris et al. 2006).
PPAR signaling pathway is one of the most frequently
changed in the liver during the overnight fasting, on the
mRNA level (Table S10). PPARs seem to be the key regula-
tors of overall metabolic processes in the cell as they are
implicated in metabolism of lipids, carbohydrates, and pro-
teins. PPARs are steroid nuclear receptors that function as
transcription factors that mediate fatty acids regulation of gene
expression, acting as the metabolic switch between fed and
fasted state. There are three isoforms of PPARs:α, β/δ, and γ,
with distinct tissue distributions and specific set of activated
target genes (Stienstra et al. 2007).
PPARγ is able to activate genes involved in lipogenesis in a
fed state. It is abundant in adipose tissue, and plays a role in
adipocyte differentiation and energy storage. Its mRNA level is
increased in the adipose tissue of obese people (Vidal-Puig et al.
1997) and its activation decreased production of inflammatory
cytokines inmacrophages (Sharma and Staels 2007). Two other
PPAR isoforms promote lipid catabolism and are found in
metabolically active tissues with high fatty acids oxidation.
PPARα is expressed mainly in the liver, brown adipose tissue,
skeletal muscle, heart, and blood cells. It is a key regulator of
energy homeostasis and plays a pivotal role in the regulation of
genes involved in fatty acids oxidation, metabolism of lipopro-
teins, gluconeogenesis, and synthesis of ketone bodies
(Mandard et al. 2004). Overall, PPARα activation decreased
hepatic fat storage. During fasting, it decreased the expression
of genes involved in the amino acids metabolism (Kersten et al.
2001). It was upregulated in mice fed with HFD (Kozawa et al.
2011). Beside metabolic processes, PPARα is also involved in
regulation of inflammation processes. Under activation, it
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reduces hepatic inflammation by interference with several pro-
inflammatory transcription factors (Delerive et al. 1999), as
well as by inhibition of cytokine signaling pathways via down-
regulation of the IL-6 receptor (Gervois et al. 2004). PPARβ/δ
is ubiquitously expressed and is less specific. Its functions are
still the least defined, although recently its role in insulin
secretion by pancreatic β-cell (Iglesias et al. 2012) and muscle
regeneration (Bonala et al. 2012) have been indicated. Alto-
gether, PPARs are among the most important processes which
allow the adaptation of metabolic and functional responses to
extracellular signals.
When assaying fasting regulated hepatic mRNAs and pro-
teins to KEGG pathways, nine pathways were selected solely
for old obese animals based on proteomic data; in turn, corre-
sponding mRNAs were annotated to twice as more differen-
tially regulated pathways in young and old mice, both lean and
obese (Table S10). Such observations may suggest that tran-
scriptional changes take place as a type of adaptive processes
in response to overnight fasting. In skeletal muscles, overnight
food deprivation, contrary to chronic obesity conditions, allow
to point several KEGG pathways for both proteomic and
corresponding transcriptomic data sets (Table S11). However,
functional annotations were limited to only two groups of
animals: young HFD-fed mice and old control mice.
In conclusion, we provide a comprehensive overview on
the molecular, mitochondria-related changes that arise during
obesity and food deprivation in two metabolically active
tissues, liver and skeletal muscles. Expression levels of genes
and proteins that accompanied the obesity and fasting states
were quantitatively different in the two studied tissues, and
both conditions inducemore pronounced proteome changes in
the liver than in the muscles.
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